BDNE was formed In 2019 to commercialize proprietary Biofine technology and is the exclusive Licensee of the IP Portfolio for the Northeast Region. This is a patented continuous chemical conversion process, enabling the economic production of third-party verified GHGnegative biofuels, biochemicals, and biochar from lingo/cellulosic feedstocks. Already there is the B2P2 Pilot Plant – Operating t University of Maine with 2,000 cumulative operating hours on a wide range of Feedstocks. BDNE’s Mike Cassata gave this overview on the progress and promise of the technology as it moves forward to commercialization at ABLC Next 2023 in San Francisco.